🕵️ Accendra Health INC/VA/ ($ACH)
SEC insider & ownership activity, last 12 months · CIK 75252 · every row links its SEC filing
Over the last 12 months insiders bought $8.1M with no open-market selling against it. Coliseum Capital Management, LLC bought $8.1M in discretionary trades (Aug). Blackrock, Inc. trimmed 14.7% → 7.1%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $8.1M (3 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Coliseum Capital Management, LLC | 3 | $8.1M | 0 | – | Aug 14, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Coliseum Capital Management, LLC | 16.9% | 13D | Nov 12, 2025 | filing ↗ | |
| Adam Gray | 16.9% | 13D | Nov 12, 2025 | filing ↗ | |
| Christopher Shackelton | 16.9% | 13D | Nov 12, 2025 | filing ↗ | |
| Coliseum Capital, LLC | 13.8% | 13D | Nov 12, 2025 | filing ↗ | |
| Coliseum Capital Partners, L.P. | 13.8% | 13D | Nov 12, 2025 | filing ↗ | |
| Blackrock, Inc. | 7.1% | 13G | Oct 2, 2025 | filing ↗ | |
| Coliseum Capital Management, LLC | 5.8% | 13G | Dec 27, 2024 | filing ↗ | |
| Adam Gray | 5.8% | 13G | Dec 27, 2024 | filing ↗ | |
| Christopher Shackelton | 5.8% | 13G | Dec 27, 2024 | filing ↗ | |
| Kevin M. Webb | 5.6% | 13G | Mar 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 9, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 9, 2026 | filing ↗ |
| Other events (8.01) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 14, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | May 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Feb 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 24, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Dec 24, 2025 | filing ↗ |
| New financial obligation (2.03) | Dec 24, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 24, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 24, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 24, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 16, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 16, 2025 | filing ↗ |